Strengthening our Health Security Through Resilient Medical Supply Chains Annual Review Act of 2021
Bill: H.R.2636 | Sponsor: Rep. Trone, David J. (D-MD)
Policy area: Health

Summary:
Strengthening our Health Security Through Resilient Medical Supply Chains Annual Review Act of 2021
This bill requires the Department of Health and Human Services (HHS) to report annually on the resiliency of U.S. medical supply chains.
In particular, HHS must assess vulnerabilities related to global disruptions and dependence on supplies produced outside of the United States in these reports. HHS must also make unclassified portions of reports publicly available.

To direct the Secretary of Health and Human Services to submit to 
 Congress a report on the security and resilience of the United States 
             medical supply chains, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Strengthening our Health Security 
Through Resilient Medical Supply Chains Annual Review Act of 2021''.

SEC. 2. REPORT ON SECURITY AND RESILIENCE OF THE UNITED STATES MEDICAL 
              SUPPLY CHAINS.

    (a) In General.--Not later than one year after the date of the 
enactment of this Act, and annually thereafter, the Secretary of Health 
and Human Services shall submit to the Committee on Energy and Commerce 
of the House of Representatives, and the Committee on Health, 
Education, Labor and Pensions of the Senate a report on the security 
and resilience of the United States medical supply chains. Such a 
report shall contain a classified annex.
    (b) Public Availability.--The Secretary shall--
            (1) make publicly available (including by publication on 
        the website of the Department of Health and Human Services) the 
        unclassified portion of the report under subsection (a); and
            (2) make every reasonable effort to protect trade secret 
        information and commercially confidential information.
    (c) Contents.--The report submitted under subsection (a) shall--
            (1) review the United States supply chains for medical 
        devices, supplies, and drugs and the vulnerability of such 
        supply chains to a global disruption, such as an instance of 
        bioterrorism, a natural disaster, or a public health emergency;
            (2) assess the dependence of the United States on any 
        medical devices, equipment, supplies, countermeasures, 
        vaccines, and drugs produced or sourced outside the United 
        States;
            (3) identify the actions the Federal government has taken 
        during the year covered by the report--
                    (A) to promote the security and resilience of the 
                United States medical supply chain;
                    (B) to improve medical supply chain redundancy;
                    (C) to encourage the domestic production of medical 
                devices, equipment, supplies, countermeasures, 
                vaccines, and drugs; and
                    (D) to develop contingency plans for potential 
                global disruptions; and
            (4) provide recommendations to agencies of the Federal 
        Government, States, local, tribal, and territorial governments, 
        and the private sector on ways to strengthen the security and 
        resilience of the United States medical supply chain.
    (d) Consultation.--In preparing the report under subsection (a), 
the Secretary of Health and Human Services--
            (1) shall consult with the heads of other relevant Federal 
        agencies; and
            (2) may consult with public health experts, health security 
        experts, supply chain experts, and other individuals with 
        relevant experience.
                                 <all>